Americas No Longer Measles-Free: Brazil Reports Cases Amidst Continental Resurgence
Despite decades of progress, the Americas have lost their measles-free status, a stark reminder of the ongoing threat posed by vaccine-preventable diseases. Brazil, while still free from endemic circulation, has registered 37 confirmed measles cases in 2025, signaling a worrying trend across the region.
The Pan American Health Organization (PAHO) confirmed the loss of certification on Monday, July 10th, following a resurgence of cases primarily driven by imported infections and declining vaccination rates. Measles, a highly contagious viral illness, can lead to severe complications including pneumonia, encephalitis, blindness, and even death, making vaccination the most effective preventative measure.
Rising Cases and Imported Infections
According to the Brazilian Ministry of Health, confirmed cases in 2025 have been identified in seven states: Tocantins (25), Mato Grosso (6), Rio de Janeiro (2), Distrito Federal (1), Maranhão (1), Rio Grande do Sul (1), and São Paulo (1). All reported cases have been classified as either imported or linked to imported infections, and authorities maintain that national certification has not been compromised.
The first indications of a potential outbreak emerged in March, when two children from the same family in São João de Meriti, Rio de Janeiro, were diagnosed with the virus.Public health officials responded swiftly, implementing contact tracing and bolstering vaccination efforts to contain the spread.”similar successful containment measures were implemented in Rio Grande do Sul, São paulo, and the Federal district,” a ministry spokesperson stated.
However, a more significant cluster of cases arose in July, originating with four Brazilian citizens returning from Bolivia infected with measles. These initial infections subsequently led to 25 additional cases, with 22 occurring within a community exhibiting low vaccination adherence. A further case in Carolina,Maranhão,was linked to contact with members of this same community. In Primavera do Leste, Mato Grosso, six cases were confirmed, including four individuals who contracted the virus while in Bolivia and two secondary infections.
Border Concerns and COP-30 Preparations
Recognizing the heightened risk, the Ministry of Health has intensified vaccination campaigns in states bordering Bolivia, Uruguay, and Argentina. Moreover,Brazil has donated over 640,000 doses of the measles vaccine to the Bolivian government in an effort to control the outbreak in the neighboring country.
The situation is compounded by a broader regional trend. Since january, a total of 12,596 confirmed measles cases have been reported across ten countries in the Americas, with 95% of these concentrated in Canada, Mexico, and the United States. Tragically, 28 deaths have been recorded: 23 in Mexico, three in the United States, and two in Canada.
The Regional Commission for Monitoring and Rechecking the Elimination of Measles, rubella and Congenital Rubella Syndrome of the Americas determined that endemic transmission had been reestablished in Canada, ultimately leading to the loss of the continent’s measles-free status. “We are committed to preventing the reintroduction of the virus within our borders,” stated Brazilian Minister of Health Alexandre Padilha. “In addition to robust surveillance,the Ministry of Health has ensured a consistent supply of immunization agents across all states.”
Preparations for the United Nations Climate Summit (COP-30), scheduled to be held in Pará state, are also driving increased vaccination efforts. Anticipating a significant influx of international travelers, the National Immunization Program (PNI) has been actively administering vaccines to the local population, with approximately 351,000 doses delivered to date.
Vaccination Coverage Declining
While brazil achieved remarkable vaccination coverage rates in 2024 – 95.80% for the first dose of the MMR vaccine and 80.43% for the second – data from 2025 reveal a concerning decline. Coverage rates have dropped to 91.51% for the first dose and 75.53% for the second.
The measles vaccine remains readily available at Basic Health Units (UBSs) for individuals aged 12 to 59 and represents the primary defense against this perhaps life-threatening disease. The recent setbacks underscore the critical importance of maintaining high vaccination rates to protect both individual and public health.
